Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin

Cardiovascular Research

Volumn 64, Issue 2, 2004, Pages 346-355

  Suárez, Yajaira ^a   Fernández, Carlos ^a   Gómez Coronado, Diego ^a   Ferruelo, Antonio J ^a   Dávalos, Alberto ^a   Martínez Botas, Javier ^a   Lasunción, Miguel A ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Cholesterol; Lipid metabolism; Lipoproteins; Receptors; Statins

Indexed keywords

1,1' DIOCTADECYL 3,3,3,3' TETRAMETHYLINDOCARBOCYANINE PERCHLORATE; CARBOCYANINE; CHOLESTEROL; ESTROGEN RECEPTOR; FILIPIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MEVINOLIN; PROTEIN; STEROL DELTA 24 REDUCTASE; STEROL DELTA 8,7 ISOMERASE; TAMOXIFEN; UNCLASSIFIED DRUG; ZYMOSTEROL;

ARTICLE; BREAST CANCER; CANCER THERAPY; CELL PROLIFERATION; CELL SURFACE; CHEMICAL LABELING; CHOLESTEROL SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STAINING; STIMULATION;

CELL LINE, TUMOR; CHOLESTEROL; CHOLESTEROL, LDL; DRUG SYNERGISM; ESTROGEN RECEPTOR MODULATORS; GENE EXPRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; LYSOSOMES; RECEPTORS, LDL; STIMULATION, CHEMICAL; TAMOXIFEN;

EID: 5444230078     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.06.024     Document Type: Article

References (47)

1. J.I. MacGregor, and V.C. Jordan Basic guide to the mechanisms of antiestrogen action Pharmacol. Rev. 50 1998 151 196
2. M. Caleffi, I.S. Fentiman, and G.M. Clark Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain J. Endocrinol. 119 1988 335 339
3. R.R. Love, P.A. Newcomb, and D.A. Wiebe Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer J. Natl. Cancer Inst. 82 1990 1327 1332
4. C.C. McDonald, and H.J. Stewart Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee Br. Med. J. 303 1991 435 437
5. J. Reckless, J.C. Metcalfe, and D.J. Grainger Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice Circulation 95 1997 1542 1548
6. J.K. Williams, J.D. Wagner, Z. Li, D.L. Golden, and M.R. Adams Tamoxifen inhibits arterial accumulation of LDL degradation products and progression of coronary artery atherosclerosis in monkeys Arterioscler. Thromb. Vasc. Biol. 17 1997 403 408
7. S.C. Clarke, P.M. Schofield, A.A. Grace, J.C. Metcalfe, and H.L. Kirschenlohr Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis Circulation 103 2001 1497 1502
8. H. Gylling, S. Pyrhonen, and E. Mantyla Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer J. Clin. Oncol. 13 1995 2900 2905
9. S.Y. Cho, J.H. Kim, and Y.K. Paik Cholesterol biosynthesis from lanosterol: differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen Mol. Cells 8 1998 233 239
10. A.L. Holleran, B. Lindenthal, T.A. Aldaghlas, and J.K. Kelleher Effect of tamoxifen on cholesterol synthesis in HepG2 cells and cultured rat hepatocytes Metabolism 47 1998 1504 1513
11. P. De Medina, B.L. Payre, and J. Bernad Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells J. Pharmacol. Exp. Ther. 308 2003 1165 1173
12. R. Callaghan, and C.F. Higgins Interaction of tamoxifen with the multidrug resistance P-glycoprotein Br. J. Cancer 71 1995 294 299
13. P. DeBry, E.A. Nash, D.W. Neklason, and J.E. Metherall Role of multidrug resistance P-glycoproteins in cholesterol esterification J. Biol. Chem. 272 1997 1026 1031
14. H. Wiseman, G. Paganga, C. Rice-Evans, and B. Halliwell Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen? Biochem. J. 292 Pt 3 1993 635 638
15. V. Guetta, R.M. Lush, W.D. Figg, M.A. Waclawiw, and R.O. Cannon 3rd Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women Am. J. Cardiol. 76 1995 1072 1073
16. Y.G. Shanker, U.P. Shetty, and A.J. Rao Regulation of low density lipoprotein receptor mRNA levels by estradiol 17beta and chorionic gonadotropin in human placenta Mol. Cell. Biochem. 187 1998 133 139
17. L. Tatidis, M. Masquelier, and S. Vitols Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines Biochem. Pharmacol. 63 2002 2169 2180
18. P. Parini, B. Angelin, and M. Rudling Importance of estrogen receptors in hepatic LDL receptor regulation Arterioscler. Thromb. Vasc. Biol. 17 1997 1800 1805
19. J.C. Bruning, P. Lingohr, and J. Gillette Estrogen receptor-alpha and Sp1 interact in the induction of the low density lipoprotein-receptor J. Steroid Biochem. Mol. Biol. 86 2003 113 121
20. M.S. Brown, and J.L. Goldstein The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340
21. C. Fernández, Y. Suárez, A.J. Ferruelo, D. Gómez-Coronado, and M.A. Lasunción Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells Biochem. J. 366 2002 109 119
22. D. Calvo, D. Gómez-Coronado, Y. Suárez, M.A. Lasunción, and M.A. Vega Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL J. Lipid Res. 39 1998 777 788
23. N. Zamzami, P. Marchetti, and M. Castedo Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death J. Exp. Med. 182 1995 367 377
24. D.M. Duhl, D.D. Gillespie, and F. Sulser Ethidium bromide fluorescence of 28S ribosomal RNA can be used to normalize samples in northern or dot blots when analyzing small drug-induced changes in specific mRNA J. Neurosci. Methods 42 1992 211 218
25. S.K. Nordeen Luciferase reporter gene vectors for analysis of promoters and enhancers Biotechniques 6 1988 454 458
26. M.R. Briggs, C. Yokoyama, X. Wang, M.S. Brown, and J.L. Goldstein Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter: I. Identification of the protein and delineation of its target nucleotide sequence J. Biol. Chem. 268 1993 14490 14496
27. Y. Suárez, C. Fernández, and B. Ledo Differential effects of ergosterol and cholesterol on Cdk1 activation and SRE-driven transcription Eur. J. Biochem. 269 2002 1761 1771
28. S.M. Sparrow, J.M. Carter, N.D. Ridgway, H.W. Cook, and D.M. Byers U18666A inhibits intracellular cholesterol transport and neurotransmitter release in human neuroblastoma cells Neurochem. Res. 24 1999 69 77
29. J.L. Goldstein, and M.S. Brown Binding and degradation of low-density lipoproteins by cultured human fibroblasts. Comparison of cells from normal and from a patient with homozygous hypercholesterolemia J. Biol. Chem. 249 1974 5153 5162
30. M. Rudling Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo J. Lipid Res. 33 1992 493 501
31. J.F. Oram, and R.M. Lawn ABCA1. The gatekeeper for eliminating excess tissue cholesterol J. Lipid Res. 42 2001 1173 1179
32. A. Venkateswaran, B.A. Laffitte, and S.B. Joseph Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha Proc. Natl. Acad. Sci. U. S. A. 97 2000 12097 12102
33. E.B. Neufeld, M. Wastney, and S. Patel The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo J. Biol. Chem. 274 1999 9627 9635
34. L. Danel, M. Menouni, and J.H. Cohen Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines Leuk. Res. 9 1985 1373 1378
35. cdc2 kinase activity and arrests the cell cycle at G2 FASEB J. 13 1999 1359 1370
36. A.L. Cheng, S.E. Chuang, and R.L. Fine Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen Biochem. Pharmacol. 55 1998 523 531
37. G.C. Ness, Z. Zhao, and D. Lopez Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation Arch. Biochem. Biophys. 325 1996 242 248
38. G.C. Ness, C.M. Chambers, and D. Lopez Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity J. Lipid Res. 39 1998 75 84
39. J.D. Butler, J. Blanchette-Mackie, and E. Goldin Progesterone blocks cholesterol translocation from lysosomes J. Biol. Chem. 267 1992 23797 23805
40. D. Gal, P.C. MacDonald, and E.R. Simpson Cholesterol metabolism in human cancer cells in monolayer culture: V. The effect of progesterone on the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by low density lipoprotein J. Clin. Endocrinol. Metab. 53 1981 29 33
41. L. Liscum, and J.R. Faust The intracelular transport of low density lipoprotein-derived cholesterol is inhibited in CHO cells cultured with 3-β-[(diethylamino)ethoxy]androst-5-en17-one J. Biol. Chem. 264 1989 11796 11806
42. A. Frolov, S.E. Zielinski, and J.R. Crowley NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols J. Biol. Chem. 278 2003 25517 25525
43. F.J. Field, E. Born, H. Chen, S. Murthy, and S.N. Mathur Esterification of plasma membrane cholesterol and triacylglycerol-rich lipoprotein secretion in CaCo-2 cells: possible role of p-glycoprotein J. Lipid Res. 36 1995 1533 1543
44. F. Hyafil, C. Vergely, P. Du Vignaud, and T. Grand-Perret In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative Cancer Res. 53 1993 4595 4602
45. B. Batetta, A. Pani, and M. Putzolu Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines Cell Prolif. 32 1999 49 61
46. M. Issandou, and T. Grand-Perret Multidrug resistance P-glycoprotein is not involved in cholesterol esterification Biochem. Biophys. Res. Commun. 279 2000 369 377
47. V.C. Jordan Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer Annu. Rev. Pharmacol. Toxicol. 35 1995 195 211